A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® (pegcetacoplan) full year 2025 net product revenue of ...

Green tea contains beneficial compounds that may support immune health by reducing inflammation, fighting oxidative stress, ...

Deep in our cells, a wide range of processes are occurring constantly. These cellular processes rely on enzymes to act as catalysts and set off a series of molecular interactions. There are still many ...

New research co-led by Burnet Institute and WEHI has uncovered how the human immune system fights Plasmodium vivax, paving the way for the first effective vaccine against the most widespread form of ...

Our bodies are home to millions of fungi that, for the most part, are completely harmless. However, they can sometimes change ...

Comprehensive analysis outlines how vascular-immune crosstalk affects cancer, cardiovascular, and metabolic disorders, revealing novel therapeutic opportunities The intricate, lifelong conversation ...

How people with compromised immune systems respond to vaccines is an important area of immunological research. A study led by York University has found that not only could machine-learning models ...

Innate immune sensors – known as pattern recognition receptors (PRRs) – detect specific molecular components of bacterial or ...

In a study of lab-engineered cells, researchers identify how the immune system neutralizes the herpesvirus. The research maps, for the first time, the maneuvers used by virus and host in the cell ...